Literature DB >> 29225087

Activation of ACE2/angiotensin (1-7) attenuates pancreatic β cell dedifferentiation in a high-fat-diet mouse model.

Xiuping Xuan1, Fei Gao2, Xiaoyi Ma1, Chenghu Huang1, Ying Wang1, Hongjun Deng1, Shiqi Wang1, Wencun Li1, Li Yuan3.   

Abstract

OBJECTIVE: Angiotensin-converting enzyme 2 (ACE2) has been identified in pancreatic islets and can preserve β cells. In this study, we aimed to examine the possible role of ACE2 and its end product, angiotensin 1-7 (A1-7), in reducing β cell dedifferentiation during metabolic stress.
METHODS: First, a lineage-tracing experiment was performed to track β cells in mice fed a high-fat diet (HFD). Second, the ACE2/A1-7 axis was evaluated in the HFD mouse model. Intraperitoneal glucose tolerance tests (IPGTTs) and intraperitoneal insulin tolerance tests (IPITTs) were conducted. Phenotypic changes in β cells were detected by immunohistochemistry and quantitative real-time PCR. Pancreatic sections were immunostained for vascular endothelial growth factor (VEGF) and inducible nitric oxide synthase (iNOS). Finally, the effects of the ACE2/A1-7 axis were explored in isolated mouse islets exposed to different concentrations of glucose. Glucose-stimulated insulin release and levels of insulin mRNA and OCT4 mRNA were measured.
RESULTS: Pancreatic β cell dedifferentiation occurred both in vitro and in vivo in response to metabolic stress and was accompanied by ACE2 reduction. HFD-induced insulin resistance and glucose intolerance were exacerbated in ACE2-knockout (ACE2KO) mice but were alleviated by exogenous A1-7 in C57BL/6J mice. Approximately 20% of β cells were dedifferentiated in ACE2KO mice fed a standard rodent chow diet (SD). A higher percentage of dedifferentiated β cells was detected in ACE2KO mice than in wild-type (WT) mice under HFD conditions. In contrast, the administration of A1-7 alleviated HFD-induced β cell dedifferentiation in C57BL/6J mice. Moreover, the exogenous injection of A1-7 improved microcirculation in islets and decreased the production of iNOS in islets of C57BL/6J mice fed an HFD. Additionally, ACE2 was found to be mainly expressed in α cells of mice, while Mas, the receptor of A1-7, was distributed in β cells.
CONCLUSIONS: Overall, this study is the first to demonstrate that the ACE2/A1-7/Mas axis may be one of the intra-islet paracrine mechanisms of communication between α and β cells. Enhancing the ACE2/A1-7 axis exerts a protective effect by ameliorating β cell dedifferentiation, and this effect might be partially mediated through improvements in islet microcirculation and suppression of islet iNOS.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  ACE2; Angiotensin 1–7; High fat diet; β cell dedifferentiation

Mesh:

Substances:

Year:  2017        PMID: 29225087     DOI: 10.1016/j.metabol.2017.12.003

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  25 in total

Review 1.  Sex differences in the metabolic effects of the renin-angiotensin system.

Authors:  Melissa C White; Rebecca Fleeman; Amy C Arnold
Journal:  Biol Sex Differ       Date:  2019-07-01       Impact factor: 5.027

2.  Sex differences in metabolic effects of angiotensin-(1-7) treatment in obese mice.

Authors:  Melissa C White; Amanda J Miller; Justin Loloi; Sarah S Bingaman; Biyi Shen; Ming Wang; Yuval Silberman; Sarah H Lindsey; Amy C Arnold
Journal:  Biol Sex Differ       Date:  2019-07-17       Impact factor: 5.027

3.  Analysis of Mortality in Patients With COVID-19: Clinical and Laboratory Parameters.

Authors:  Sufang Tian; Huan Liu; Meiyan Liao; Yingjie Wu; Chunxiu Yang; Yuxiang Cai; Zhiyong Peng; Shu-Yuan Xiao
Journal:  Open Forum Infect Dis       Date:  2020-04-29       Impact factor: 3.835

4.  Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System.

Authors:  Mengying Yang; Xiaoyi Ma; Xiuping Xuan; Hongjun Deng; Qi Chen; Li Yuan
Journal:  Front Pharmacol       Date:  2020-04-08       Impact factor: 5.810

Review 5.  Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence.

Authors:  Celestino Sardu; Jessica Gambardella; Marco Bruno Morelli; Xujun Wang; Raffaele Marfella; Gaetano Santulli
Journal:  J Clin Med       Date:  2020-05-11       Impact factor: 4.241

6.  SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature.

Authors:  Daniela Fignani; Giada Licata; Noemi Brusco; Laura Nigi; Giuseppina E Grieco; Lorella Marselli; Lut Overbergh; Conny Gysemans; Maikel L Colli; Piero Marchetti; Chantal Mathieu; Decio L Eizirik; Guido Sebastiani; Francesco Dotta
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-13       Impact factor: 5.555

Review 7.  Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review.

Authors:  Amany Magdy Beshbishy; Victor B Oti; Diaa E Hussein; Ibrahim F Rehan; Oluyomi S Adeyemi; Nallely Rivero-Perez; Adrian Zaragoza-Bastida; Muhammad Ajmal Shah; Khaled Abouelezz; Helal F Hetta; Natália Cruz-Martins; Gaber El-Saber Batiha
Journal:  Front Public Health       Date:  2021-07-07

Review 8.  Expression of SARS-CoV-2 receptor "ACE2" in human pancreatic β cells: to be or not to be!

Authors:  Waseem El-Huneidi; Mawieh Hamad; Jalal Taneera
Journal:  Islets       Date:  2021-07-24       Impact factor: 2.308

9.  The impact of type 2 diabetes and its management on the prognosis of patients with severe COVID-19.

Authors:  Zihui Xu; Zhongjing Wang; Shuo Wang; Yingchun Ye; Deng Luo; Li Wan; Ailin Yu; Lifang Sun; Solomon Tesfaye; Qingtao Meng; Ling Gao
Journal:  J Diabetes       Date:  2020-08-16       Impact factor: 4.530

10.  SARS-CoV-2 Host Receptor ACE2 Protein Expression Atlas in Human Gastrointestinal Tract.

Authors:  Xiang An; Wenlong Lin; Huan Liu; Weixiang Zhong; Xiuming Zhang; Yimin Zhu; Xiaojian Wang; Jun Li; Qinsong Sheng
Journal:  Front Cell Dev Biol       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.